Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.
about
Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft modelEffective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1Structure-based design and synthesis of a bivalent iminobiotin analog showing strong affinity toward a low immunogenic streptavidin mutantStructure-based design of a streptavidin mutant specific for an artificial biotin analogueRadioimmunotherapy of human tumoursMolecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.Success of measles virotherapy in ATL depends on type I interferon secretion and responsiveness.Preclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the beta-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma.Pretargeted radioimmunotherapy for hematologic and other malignanciesConventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.The potential and hurdles of targeted alpha therapy - clinical trials and beyond.Radioimmunotherapy with α-particle-emitting radionuclides.Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinomaMeasles virotherapy in a mouse model of adult T-cell leukaemia/lymphomaConscripts of the infinite armada: systemic cancer therapy using nanomaterials.Antibody-based treatment of acute myeloid leukaemia.ABCs of radioisotopes used for radioimmunotherapy: alpha- and beta-emitters.(212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease.Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas.Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25Adult T cell leukemia lymphoma.124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET.Human T cell lymphotropic virus-associated leukemia/lymphomaTailoring antibodies for radionuclide delivery.Advances in radioimmunotherapy in the age of molecular engineering and pretargeting.Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy.Targeted alpha-therapy: past, present, future?Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia.A versatile bifunctional dendritic cell targeting vaccine vectorA comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates.Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.Advances in the treatment of hematologic malignancies using immunoconjugatesRadioimmunotherapy for hematopoietic cell transplantation.Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus.Use of iodine 131I-tositumomab radioimmunotherapy in a patient with Waldenstrom's macroglobulinemia.Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.
P2860
Q24629826-3C117231-C049-43E0-8199-56FEBC0751DAQ24685212-A8D12DC3-AD91-4CF6-B0F2-E6E752785E42Q27697299-6C65114E-2EF8-4CE7-BA85-869763F9F0EDQ27697883-7CE9C4FF-0FBD-482F-9EF7-4761141BB5A0Q28088825-A8EDF5A2-AB55-492C-8343-C36C26C944F2Q31085503-FAA77963-48CD-4EEC-A1FC-426B2F7AED9EQ34053730-39A29A8A-A615-4324-B600-A75BBED59CEFQ34077332-7E51898D-1EAE-43D2-8B90-22C172EF8EC2Q34113941-1AD4921E-150A-42EF-A663-B01CE98A47A0Q34360360-7E233948-891C-4AD8-B0F0-0FCE5785DD33Q34399879-642924B8-30A3-46E8-A756-4497FE54EF90Q34419562-3E7A1507-8D1E-463F-BB15-EE9FBC53EC2BQ35059542-47ED081E-2036-4587-8125-20E1AB41BE42Q35200122-1B4DF2B4-E7D0-4AAB-AD7A-208832745A9BQ35545342-44694CC4-E523-4B22-9875-8D828B4CDB93Q35609792-B9A55480-E374-4DF2-990F-82558A71E239Q35808435-F51406DB-05A5-4CFB-8B46-F1E18D77B102Q35815494-9DCB0CEB-1BBC-4ED5-B6D9-43C3108DA039Q35849837-05877E61-00BB-4037-BC7B-53D6EAE78B0CQ35849893-D6AA3C80-21F3-4BB0-9A68-76EB10D3B21CQ35880693-9DBD6D79-B0F9-4B71-8B56-B2C9B9F44AADQ36088136-7F3C5312-6671-4427-B10A-1478ADD4AA6FQ36225607-B278AC8C-2728-4AB9-934F-E262DB2BDA8EQ36349687-12240BEE-4AF5-4EC1-995D-7D698BA38B3CQ36391426-1D8B5B1C-C1F6-4681-B106-9E0246C48F1CQ36395999-1EB03BB9-1C47-4776-B6EF-0C0F98AA8ABBQ36445890-CAC2EBD2-2D8E-46D9-82EC-08D32DFE135FQ36691184-EFA53AF0-B8E9-4D4A-B5DE-113276F8F069Q37036289-DAB1C408-C909-4669-B5B6-6B338D49EEAEQ37183994-7EFB382C-C12A-404C-90F7-F52F17E1AACAQ37201878-EAAFAD2A-3AA1-4DA2-9965-4BB5FC33EDB7Q37295150-B5689F11-454A-4FEE-8BFC-C45491861607Q37412334-E2EB26CD-7643-4DE7-91AD-8FD442B04695Q37697843-71B5E5D1-99C5-4C19-B057-B8B4A359EE6DQ38096058-DA577B45-0A2E-4F85-97DE-26FA514D3944Q40479713-D4307373-5A98-409D-8938-28305B7850B5Q47435794-07C71FC1-0EB7-43F1-A696-09B5C5145006Q48298566-A6F5B929-C5F8-4E92-A0E2-2D14AB869A48
P2860
Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pretarget radiotherapy with an ...... leukemia/lymphoma xenografts.
@ast
Pretarget radiotherapy with an ...... leukemia/lymphoma xenografts.
@en
Pretarget radiotherapy with an ...... leukemia/lymphoma xenografts.
@nl
type
label
Pretarget radiotherapy with an ...... leukemia/lymphoma xenografts.
@ast
Pretarget radiotherapy with an ...... leukemia/lymphoma xenografts.
@en
Pretarget radiotherapy with an ...... leukemia/lymphoma xenografts.
@nl
prefLabel
Pretarget radiotherapy with an ...... leukemia/lymphoma xenografts.
@ast
Pretarget radiotherapy with an ...... leukemia/lymphoma xenografts.
@en
Pretarget radiotherapy with an ...... leukemia/lymphoma xenografts.
@nl
P2093
P2860
P921
P356
P1476
Pretarget radiotherapy with an ...... leukemia/lymphoma xenografts.
@en
P2093
Carolyn K Goldman
Donald B Axworthy
Jody Schultz
Kayhan Garmestani
Martin W Brechbiel
Meili Zhang
Thomas A Waldmann
Zhuo Zhang
P2860
P304
P356
10.1073/PNAS.0437788100
P407
P577
2003-02-04T00:00:00Z